Author

Antal Bajor 1

1 Medicine, Internal Medicine And Clinical Nutrition, Gothenburg, Sweden

ANTI-TNF THERAPY RESPONSE IS ASSOCIATED WITH LOWER MUCOSAL EXPRESSION OF INFLAMMATORY CYTOKINES BEFORE THERAPY START IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Rahil Dahlén, Maria K. Magnusson, Hans Strid, Antal Bajor, Anders Lasson, Kjell Arne Ung, Lena Öhman

REDUCED MONOCYTE ACTIVATION AND RECRUITMENT TWO WEEKS AFTER TREATMENT START REFLECT EARLY INFLIXIMAB THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS

Maria K. Magnusson, Hans Strid, Anders Lasson, Kjell Arne Ung, Antal Bajor, Lena Öhman

THE EFFICACY OF CHOLESTYRAMINE TREATMENT IN PATIENTS INVESTIGATED FOR BILE ACID DIARRHOEA

Nima Mottacki, Magnus Simrén, Kjell Arne Ung, Antal Bajor

THE DIAGNOSTIC YIELD OF THE 75SEHCAT TEST IN PATIENTS WITH CHRONIC DIARRHOEA

Nima Mottacki, Magnus Simrén, Kjell Arne Ung, Antal Bajor

T CELL EXPRESSION OF CD25 AND TNF RECEPTOR 2 AND IL-1B RELEASE MAY PREDICT ANTI-TNF THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS

Maria K. Magnusson, Hans Strid, Kjell Arne Ung, Lena Öhman, Rahil Dahlén, Anders Lasson, Kjell Arne Ung, Antal Bajor

CHOLECYSTECTOMY DOES NOT INFLUENCE GASTROINTESTINAL TRANSIT: RESULTS OF A PROSPECTIVE STUDY USING RADIO-OPAQUE MARKERS

Nima Mottacki, Magnus Simrén, Kjell Arne Ung, Antal Bajor, Kjell Arne Ung

CULTURED BLOOD T CELLS AS A PROGNOSTIC BIOMARKER FOR ANTI-TNF THERAPY RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS

Maria K. Magnusson, Hans Strid, Antal Bajor, Anders Lasson, Kjell Arne Ung, Lena Öhman

LONG-TERM OUTCOME IN PATIENTS WITH CHRONIC ACTIVE ULCERATIVE COLITIS STARTED ON INFLIXIMAB: A RETROSPECTIVE SWEDISH MULTICENTER STUDY

Leif Angelison, Sven Almer, Antal Bajor, Jan Björk, Michael Eberhardsson, Anders Eriksson, Olof Grip, Per Hammarlund, Ulf Hindorf, Pontus Karling, Mari Thörn, Jörgen Torp, Erik Hertervig

INCREASED COLONIC BILE ACID EXPOSURE: A RELEVANT FACTOR FOR SYMPTOMS AND TREATMENT IN IRRITABLE BOWEL SYNDROME (IBS).

Antal Bajor

INCREASED COLONIC BILE ACID EXPOSURE: A RELEVANT FACTOR FOR SYMPTOMS AND TREATMENT IN IRRITABLE BOWEL SYNDROME (IBS).

Mats Rudling, Hans Törnblom, Kjell Arne Ung, Magnus Simrén, Antal Bajor, Kjell Arne Ung

Item 1 - 10 / 12
1
2